📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19. (2021)

First Author: Capone S

Attributed to: Assessing the impact of host and virus genetic variability on Filovirus cell entry and infectivity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ymthe.2021.04.022

PubMed Identifier: 33895322

Publication URI: http://europepmc.org/abstract/MED/33895322

Type: Journal Article/Review

Volume: 29

Parent Publication: Molecular therapy : the journal of the American Society of Gene Therapy

Issue: 8

ISSN: 1525-0016